0000905718-20-000969.txt : 20200917
0000905718-20-000969.hdr.sgml : 20200917
20200917210719
ACCESSION NUMBER: 0000905718-20-000969
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200915
FILED AS OF DATE: 20200917
DATE AS OF CHANGE: 20200917
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zarrabian Saiid
CENTRAL INDEX KEY: 0001495521
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37823
FILM NUMBER: 201182564
MAIL ADDRESS:
STREET 1: P.O. BOX 675765
CITY: RANCHO SANTA FE
STATE: CA
ZIP: 92067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kintara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001498382
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 990360497
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 12707 HIGH BLUFF DR., SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 350-4364
MAIL ADDRESS:
STREET 1: 12707 HIGH BLUFF DR., SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: DelMar Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20130123
FORMER COMPANY:
FORMER CONFORMED NAME: Berry Only Inc.
DATE OF NAME CHANGE: 20100805
4
1
kintara_fm4sep152020.xml
X0306
4
2020-09-15
0
0001498382
Kintara Therapeutics, Inc.
KTRA
0001495521
Zarrabian Saiid
12707 HIGH BLUFF DR., SUITE 200
SAN DIEGO
CA
92130
1
1
0
0
President and CEO
Options (Right to Buy)
1.70
2020-09-15
4
A
0
2715004
0
A
2030-09-15
Common Stock
2715004
2715004
D
The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued employment, 1/6th of the options vest on March 15, 2021, with the remaining shares vesting in equal monthly installments over a period of 30 months commencing on April 15, 2021.
/s/ Anthony Scott Praill, attorney-in-fact for Saiid Zarrabian
2020-09-17